CN111448322B - 使用苹果乳杆菌制造转果糖基化甜菊醇配糖物的方法 - Google Patents
使用苹果乳杆菌制造转果糖基化甜菊醇配糖物的方法 Download PDFInfo
- Publication number
- CN111448322B CN111448322B CN201880079763.6A CN201880079763A CN111448322B CN 111448322 B CN111448322 B CN 111448322B CN 201880079763 A CN201880079763 A CN 201880079763A CN 111448322 B CN111448322 B CN 111448322B
- Authority
- CN
- China
- Prior art keywords
- steviol glycoside
- transglucosylated
- lactobacillus
- rebaudioside
- malus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000019202 steviosides Nutrition 0.000 title claims abstract description 131
- 150000008144 steviol glycosides Chemical class 0.000 title claims abstract description 117
- 239000004383 Steviol glycoside Substances 0.000 title claims abstract description 116
- 235000019411 steviol glycoside Nutrition 0.000 title claims abstract description 116
- 229930182488 steviol glycoside Natural products 0.000 title claims abstract description 116
- 241000186660 Lactobacillus Species 0.000 title claims abstract description 41
- 229940039696 lactobacillus Drugs 0.000 title claims abstract description 41
- 241000220225 Malus Species 0.000 title claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 24
- 239000008103 glucose Substances 0.000 claims description 24
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 21
- 244000005700 microbiome Species 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 19
- 229940013618 stevioside Drugs 0.000 claims description 17
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 15
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 claims description 8
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims description 7
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 claims description 6
- -1 dulcitol glycoside Chemical class 0.000 claims description 5
- 239000001776 FEMA 4720 Substances 0.000 claims description 4
- 241000186851 Lactobacillus mali Species 0.000 claims description 4
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 claims description 2
- 229930182470 glycoside Natural products 0.000 claims description 2
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 claims description 2
- QRGRAFPOLJOGRV-UHFFFAOYSA-N rebaudioside F Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(OC6OCC(O)C(O)C6O)C5OC7OC(CO)C(O)C(O)C7O)C(=O)OC8OC(CO)C(O)C(O)C8O QRGRAFPOLJOGRV-UHFFFAOYSA-N 0.000 claims description 2
- GSGVXNMGMKBGQU-PHESRWQRSA-N rebaudioside M Chemical compound C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GSGVXNMGMKBGQU-PHESRWQRSA-N 0.000 claims description 2
- HYLAUKAHEAUVFE-AVBZULRRSA-N rebaudioside f Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HYLAUKAHEAUVFE-AVBZULRRSA-N 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 29
- 108090000790 Enzymes Proteins 0.000 abstract description 29
- 238000006243 chemical reaction Methods 0.000 description 32
- 239000000243 solution Substances 0.000 description 26
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000001512 FEMA 4601 Substances 0.000 description 11
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 11
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 11
- 235000003599 food sweetener Nutrition 0.000 description 11
- 229940049920 malate Drugs 0.000 description 11
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 11
- 235000019203 rebaudioside A Nutrition 0.000 description 11
- 239000003765 sweetening agent Substances 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 238000005100 correlation spectroscopy Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- YSCJAYPKBYRXEZ-HZPINHDXSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YSCJAYPKBYRXEZ-HZPINHDXSA-N 0.000 description 5
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000008123 high-intensity sweetener Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 235000021096 natural sweeteners Nutrition 0.000 description 4
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 4
- 244000228451 Stevia rebaudiana Species 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 241000186604 Lactobacillus reuteri Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000006903 response to temperature Effects 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000001551 total correlation spectroscopy Methods 0.000 description 2
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 description 1
- CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- GIPHUOWOTCAJSR-UHFFFAOYSA-N Rebaudioside A. Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1OC(C1O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O GIPHUOWOTCAJSR-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- NIKHGUQULKYIGE-SHAPNJEPSA-N ent-kaur-16-en-19-oic acid Chemical compound C([C@H]1C[C@]2(CC1=C)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 NIKHGUQULKYIGE-SHAPNJEPSA-N 0.000 description 1
- KWVKUAKMOIEELN-UHFFFAOYSA-N ent-kaur-16-en-19-oic acid Natural products CC1(C)CCCC2(C)C1CCC34CC(=C(C3)C(=O)O)CCC24 KWVKUAKMOIEELN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- NIKHGUQULKYIGE-UHFFFAOYSA-N kaurenoic acid Natural products C1CC2(CC3=C)CC3CCC2C2(C)C1C(C)(C(O)=O)CCC2 NIKHGUQULKYIGE-UHFFFAOYSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000035440 response to pH Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/24—Non-sugar sweeteners
- A23V2250/262—Stevioside
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本申请涉及使用苹果乳杆菌菌株的粗酶液制备转葡糖基化甜菊醇配糖物的方法。
Description
技术领域
本公开涉及使用苹果乳杆菌(Lactobacillus mali)菌株的粗酶液以制备转葡糖基化甜菊醇配糖物(steviol glycoside)的方法。
背景技术
随着世界卫生组织(WHO)出于对糖消耗引起疾病(肥胖)的担忧,建议降低每日糖摄入量,发达国家政府正在积极讨论旨在减少糖摄入量的各种政策。因此,随着市场上开发各种替代增甜剂的需求不断增加,替代增甜剂正在不断被开发和商业化。作为替代增甜剂,这些是以下列的形式持续变化:合成高强度增甜剂(例如,糖精、阿斯巴甜、三氯蔗糖(Sucralose)等)、合成糖醇(例如,麦芽糖醇和木糖醇)、和高强度增甜剂(例如,新蛇菊苷(Rebaudioside)A和甘草)。然而,由于对合成增甜剂的安全性的担忧,消费者对天然增甜剂的需求一直在稳定增加;然而,因为天然增甜剂特有的风味特性(即,异味(off-oder)和败味(off-flavor))的限制,所以天然增甜剂不能完全取代现有的以合成增甜剂为基础的低卡路里和零卡路里产品。
近年来备受关注的天然高强度增甜剂是从甜叶菊(Stevia rebaudiana Bertoni)的叶中提取的甜菊糖苷(stevia)。甜菊糖苷是天然材料,其甜度是糖的甜度的200至300倍。进一步,甜菊糖苷由蛇菊苷(Stevioside)、新蛇菊苷A、B、C、D、E和M等组成。此外,因为据报道,甜菊糖苷不产生卡路里,其对血糖和胰岛素水平具有正面作用,而且它对人体没有副作用,所以甜菊糖苷具有作为替代增甜剂的潜在用途;然而,甜菊糖苷有苦味,其在使用上有一定的局限性。
迄今为止,已经有三种方法来改善甜菊糖苷的甜味:(1)与糖类增甜剂、氨基酸、或氨基酸盐混合的方法,(2)包括诸如环糊精的物质的物理方法;以及(3)使用酶转移葡萄糖的方法。作为使用酶转移葡萄糖的方法,使用环糊精葡萄糖基转移酶(CGTase)将1至12个葡萄糖分子转移到甜菊醇配糖物的方法在本领域广泛使用(韩国专利申请号10-1991-0020769)。然而,这种方法具有以下有缺点:所有转移到甜菊醇配糖物的葡萄糖都被肠道微生物降解,从而增加了卡路里。
已知一般乳酸杆菌在与β-葡萄糖苷酶反应时产生甜茶苷(rubusoside)(韩国专利申请号10-17676060000)。此外,特定的基因组路氏乳杆菌(Lactobacillus reuteri)180是已知的唯一能识别甜菊醇配糖物以产生转葡糖基化甜菊醇配糖物的乳酸杆菌。
发明内容
[技术问题]
在这种情况下,本发明人通过发现苹果乳杆菌通过α-(1,6)-键将葡萄糖转葡糖基化到甜菊醇配糖物以产生难以消化的转葡糖基化甜菊醇配糖物来完成了本公开。
[技术手段]
本公开的目的是提供使用苹果乳杆菌微生物或其培养物制备转葡糖基化甜菊醇配糖物的方法。
本公开的另一目的是提供经由上述制备方法制备的转葡糖基化甜菊醇配糖物。
本公开的又一目的是提供用于生产转葡糖基化甜菊醇配糖物的组合物,其包含苹果乳杆菌微生物或其培养物。
本公开的又一目的是提供增甜剂,其包含使用苹果乳杆菌微生物或其培养物通过上述制备方法制备的转葡糖基化甜菊醇配糖物。
[有益效果]
本公开的用于制备转葡糖基化甜菊醇配糖物的方法,可具体地利用苹果乳杆菌微生物或其培养物生产转葡糖基化甜菊醇配糖物。此外,苹果乳杆菌微生物或其培养物具有从甜菊醇配糖物转化成转葡糖基化甜菊醇配糖物的高转化率,且因此可有效地生产转葡糖基化甜菊醇配糖物。根据本公开的转葡糖基化甜菊醇配糖物是具有改善苦味的高强度增甜剂的材料,并且其卡路里含量与已知的转葡糖基化甜菊醇配糖物相比并不高,且从而可被用于各种领域。
附图说明
图1至9显示了使用苹果乳杆菌的粗酶液制备的转葡糖基化甜菊醇配糖物的HPLC结果。
图10至16显示了使用苹果乳杆菌菌株的粗酶液制备的转葡糖基化甜菊醇配糖物的HPLC/MS结果。
图17是显示转葡糖基化甜菊醇配糖物(蛇菊苷和新蛇菊苷A)根据温度的转化率的图表。
图18是显示转葡糖基化甜菊醇配糖物(蛇菊苷和新蛇菊苷A)根据pH的转化率的图表。
图19是显示转葡糖基化甜菊醇配糖物根据甜菊醇配糖物(蛇菊苷和新蛇菊苷A)的浓度的转化率的图表。
[技术方案]
在下文,将详细描述本公开。同时,本文公开的每个解释和示例性实施方式可应用于其它解释和示例性实施方式。即,本文公开的各种要素的所有组合都属于本公开的范围。此外,本公开的范围不应受下文提供的具体公开的限制。
为了实现本公开的目的,本公开的一方面提供了使用苹果乳杆菌微生物或其培养物制备转葡糖基化甜菊醇配糖物的方法。
如本文所用,术语“甜菊醇配糖物”是指具有连接到化学式1的13-OH或19-OH的葡萄糖、鼠李糖、木糖等的天然增甜剂:
[化学式1]
通常,在化学式1中,在R1处,可结合氢(H),或可经由β-键结合1至3个葡萄糖分子;以及在R2处,可经由β-键结合葡萄糖、木糖和鼠李糖中的任一个,并且可以经由β-键与其结合0至2个葡萄糖分子,但这些不限于此。
甜菊醇配糖物的优点在于,与糖相比,其具有更少的卡路里,且其甜度为糖的甜度的约200至300倍;但缺点在于其伴随着独特的涩味或苦味。因此,一直努力改善甜菊醇配糖物的甜度。
α-/β-糖苷键通过异头位置(anomeric position)和离单糖的1-碳最远的立体中心(stereocenter)的相对立体化学(R型或S型)来区分。一般来说,当两个碳具有相同的立体化学时,形成α-糖苷键,而当两个碳具有不同的立体化学时,出现β-糖苷键。
本发明人首次发现了,苹果乳杆菌微生物及其培养物利用糖和甜菊醇配糖物作为底物将糖分解成葡萄糖,并且通过α-键将1至4个葡萄糖分子选择性地连接到甜菊醇配糖物。此外,本发明人首次发现了,源自本公开的苹果乳杆菌的酶的优点在于,它们在转化成转葡糖基化甜菊醇配糖物的方面具有优良转化率,并且与现有甜菊醇配糖物相比,其气味减少且其甜度显著增加。
如本文所用,术语“转葡糖基化甜菊醇配糖物”可指具有以下形式的甜菊醇配糖物,在该形式中通过使用糖和甜菊醇配糖物作为底物,将1至4个葡萄糖分子通过苹果乳杆菌经由α-键直接添加到甜菊醇配糖物的19-OH位点。更具体地,转葡糖基化甜菊醇配糖物可以处于以下形式,在该形式中1至4个葡萄糖分子通过α-(1,6)键被添加到与甜菊醇配糖物的19-OH位点连接的葡萄糖,但不限于此。
将详细描述制备转葡糖基化甜菊醇配糖物的方法的每个步骤。首先,在该方法中,可以制备苹果乳杆菌微生物或其培养物。
在制备转葡糖基化甜菊醇配糖物的方法的下一步骤中,糖可以在苹果乳杆菌微生物或其培养物的存在下与甜菊醇配糖物反应。
为了本公开的目的,培养物可以是指含有细胞的培养基或不含细胞的粗酶液。具有糖水解活性的酶可发挥选择性地将1至4个葡萄糖分子与甜菊醇配糖物的19-OH位点连接的葡萄糖α-结合的作用,但不限于此。
本文,甜菊醇配糖物可以是选自蛇菊苷、甜茶苷、卫矛醇苷A(Dulcoside A)、新蛇菊苷A、新蛇菊苷C、新蛇菊苷D、新蛇菊苷E、新蛇菊苷F、和新蛇菊苷M中的一种或多种,但不限于此。
进一步,使糖与甜菊醇配糖物反应的步骤可以在1至10的pH下、更具体地在2至9的pH下、或在3至8的pH下进行,但pH不限于此。
此外,使糖与甜菊醇配糖物反应的步骤可以在1℃至80℃的温度下进行、更具体地在5℃至70℃、10℃至60℃、或25℃至50℃的温度下进行,但温度不限于此。
此外,具有转葡糖基化甜菊醇配糖物特征的苹果乳杆菌的特征在于,与含有已知酶的其它微生物相比,具有从甜菊醇配糖物到转葡糖基化甜菊醇配糖物的更高转化率。
转化成本公开的转葡糖基化甜菊醇配糖物的转化率可以为40%至90%,但不限于此。更具体地,转化率可以是40%至90%、50%至80%、50%至85%、60%至85%、60%至80%、70%至85%、或70%至80%,但不限于此。
更具体地,转化率在以下条件下被测量:其中将在30℃下培养24小时至48小时的其中具有转糖基化甜菊醇配糖物特征的苹果乳杆菌的培养基在4000rpm至8000rpm下离心1分钟至20分钟,以分离细胞以及使粗酶液与含有甜菊醇配糖物和糖的底物溶液反应。
为了实现本公开的目的,本公开的另一方面提供了通过上述制备方法制备的转葡糖基化甜菊醇配糖物。转葡糖基化甜菊醇配糖物可以处于以下形式,在该形式中将1至4个葡萄糖分子经由α-键直接添加到甜菊醇配糖物的19-OH位点;以及更具体地,可以处于以下形式,在该形式中将1至4个葡萄糖分子经由α-(1,6)键直接添加到甜菊醇配糖物的19-OH位点,但不限于此。
更具体地,根据上述方法制备的转葡糖基化甜菊醇配糖物可以是选自转葡糖基化蛇菊苷、转葡糖基化甜茶苷、转葡糖基化卫矛醇苷A、转葡糖基化新蛇菊苷A、转葡糖基化新蛇菊苷C、转葡糖基化新蛇菊苷D、转葡糖基化新蛇菊苷E、转葡糖基化新蛇菊苷F、和转葡糖基化新蛇菊苷M中的一种或多种,但不限于此。
本公开的又一方面提供了用于生产转葡糖基化甜菊醇配糖物的组合物,其包含苹果乳杆菌微生物或其培养物。
本公开的又一方面提供了增甜剂,其包含通过该方法制备的转葡糖基化甜菊醇配糖物。为了本公开的目的,增甜剂的特征在于具有减少的异味和增强的甜度。
本公开的又一方面提供了增强增甜剂甜度的方法,其包括使用苹果乳杆菌微生物或其培养物生产转葡糖基化甜菊醇配糖物。
具体实施方式
在下文,将结合随附的示例性实施方式详细描述本公开。然而,本文公开的示例性实施方式仅用于说明性目的,并且不应被解释为限制本公开的范围。
实施例1:具有糖水解活性的新型源自苹果乳杆菌的酶的制备方法
在含有酵母提取物和玉米浆作为氮源、糖(纯度为99%或更高的Beksul白糖)作为碳源、氨基酸等的营养培养基中,在30℃下单独培养了苹果乳杆菌微生物(DSM20444、ATCC27054、ATCC 27304)24小时。将培养基(培养物)在8000rpm下离心10分钟,以分离细胞和上清液,以及然后仅收集了上清液。使粗酶液与糖反应,这导致糖水解活性,并且这确认了具有糖水解活性的新型酶存在于粗酶液中。
实施例2:从甜菊醇配糖物转化成转葡糖基化甜菊醇配糖物的评价
将甜菊醇配糖物和糖溶解在0.05M乙酸盐缓冲溶液中,并且向其中添加了实施例1中已经制备的苹果乳杆菌菌株的粗酶液,然后在40℃下反应24小时。反应后,将反应溶液在100℃下灭活,以及然后通过HPLC确认了转葡糖基化甜菊醇配糖物的产生。使用的甜菊醇配糖物是蛇菊苷、甜茶苷、卫矛醇苷A、和新蛇菊苷A/C/D/E/F/M,并且通过HPLC确定了是否它们产生转葡糖基化蛇菊苷、转葡糖基化甜茶苷、转葡糖基化卫矛醇苷A、和转葡糖基化新蛇菊苷A/C/D/E/F/M。具体地,基于图1至9为了鉴定通过苹果乳杆菌菌株的粗酶液与甜菊醇配糖物之间的反应而新产生的物质,通过进行HPLC/MS分析确定了该物质是转葡糖基化甜菊醇配糖物。进行HPLC/MS分析的甜菊醇配糖物是蛇菊苷、新蛇菊苷A/C/D/E/F/M、甜茶苷和卫矛醇苷A。
图10至16显示了使用苹果乳杆菌菌株的粗酶液制备的转葡糖基化甜菊醇配糖物的HPLC/MS分析的结果。通过图10至16确认了在使用苹果乳杆菌菌株的粗酶液制备的转葡糖基化甜菊醇配糖物中,1至4个葡萄糖分子被转移到甜菊醇配糖物(蛇菊苷、新蛇菊苷A/C/E/F、甜茶苷、和卫矛醇苷A)。
实施例3:温度对转葡糖基化甜菊醇配糖物合成的影响
在通过源自苹果乳杆菌菌株的粗酶液的转葡糖基化甜菊醇配糖物的生产中,评价了温度的影响。将甜菊醇配糖物(蛇菊苷和新蛇菊苷A)和糖溶解于0.05M乙酸缓冲溶液(pH5.0)中,并且向其中添加了粗酶液,然后在10℃至80℃下反应24小时。反应后,通过HPLC分析了反应溶液中转葡糖基化甜菊醇配糖物的量。
图17是显示转葡糖基化甜菊醇配糖物(蛇菊苷和新蛇菊苷A)根据温度的转化率的图表。基于图17,通过苹果乳杆菌菌株的粗酶液向转葡糖基化甜菊醇配糖物的转化率在10℃至50℃下高达10%至70%。
实施例4:pH对转葡糖基化甜菊醇配糖物合成的影响
在通过苹果乳杆菌菌株的粗酶液的转葡糖基化甜菊醇配糖物的生产中,评价了pH的影响。将甜菊醇配糖物和糖溶解在0.05M乙酸缓冲溶液(pH 2.0至pH 5.0)、磷酸盐缓冲溶液(pH 6.0)、Tris缓冲溶液(pH 7.0至pH 8.0)、和碳酸氢钠缓冲溶液(pH 9.0)中。此后,粗酶液被添加至其中,在pH 2至pH 9下进行反应24小时。反应后,通过HPLC分析了转糖基化甜菊醇配糖物的量。
图18是显示转葡糖基化甜菊醇配糖物根据pH的合成转化率的图表。基于图18,通过苹果乳杆菌菌株的粗酶液向转葡糖基化甜菊醇配糖物的转化率在pH 4.0至pH 7.0下高,且特别地,在pH 5.0下显示了最高转化率90%。
实施例5:根据甜菊醇配糖物浓度的转葡糖基化甜菊醇配糖物的分析
评价了通过苹果乳杆菌的粗酶液,根据甜菊醇配糖物的浓度的转葡糖基化甜菊醇配糖物的生产。将糖和甜菊醇配糖物(蛇菊苷和新蛇菊苷A)溶解于乙酸缓冲溶液(pH 5.0)中,以及在40℃下进行反应24小时。反应后,通过HPLC对转葡基化甜菊醇配糖物的生产进行了分析。
图18是显示转葡糖基化甜菊醇配糖物根据甜菊醇配糖物的浓度的转化率的图表。结果,确认了通过苹果乳杆菌的粗酶液向转葡糖基化甜菊醇配糖物的转化率在0%(w/w)到4%(w/w)是高的,且特别地,在6%(w/w)是最高的。
图18显示了转葡糖基化新蛇菊苷A根据新蛇菊苷A的浓度的合成转化率。结果,确认了通过苹果乳杆菌的粗酶液向转葡糖基化新蛇菊苷A的转化率在0%(w/w)至32%(w/w)是高的,且特别地,在6%(w/w)是最高的。
实施例6:转葡糖基化甜菊醇配糖物的核磁共振(NMR)分析
将糖和甜菊醇配糖物溶解在乙酸缓冲溶液(pH 5.0)中,以及然后向其中添加了粗酶液,然后在40℃下反应24小时。将反应溶液在100℃下灭活,以及然后使用0.45μm过滤器移除杂质。利用HP20树脂,对其中转移了一个葡萄糖的甜菊醇配糖物(蛇菊苷和新蛇菊苷A)中的每个,进行了纯分离。通过1H/13C NMR、同核相关谱(homonuclear correlationspectroscopy,COSY)、全相关谱(total correlation spectroscopy,TOCSY)、异核单量子相干谱(heteronuclear single-quantum coherence,HSQC)、和异核多键相关谱(heteronuclear multiple-bond correlation,HMBC)对分离的转葡糖基化蛇菊苷和转葡糖基化新蛇菊苷A的键结构进行了分析。另外,其结果(1H/13C NMR、COSY和HMBC)示于表1和表2中。
另外,作为鉴定转葡糖基化蛇菊苷和转葡糖基化新蛇菊苷A的结构的结果,确认了这些是新型化合物,如转葡糖基化蛇菊苷是13-[(2-O-β-D-吡喃葡糖(苷基)-β-D-吡喃葡糖(苷基))氧基]对映-贝壳杉-16-烯-19-酸6-O-α-D-吡喃葡糖(苷基)-β-D-吡喃葡糖(苷基)酯(13-[(2-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]ent-kaur-16-en-19-oicacid6-O-α-D-glucopyranosyl-β-D-glucopyranosyl ester)和转葡糖基化新蛇菊苷A是13-[(2-O-β-D-吡喃葡糖(苷基)-3-O-β-D-吡喃葡糖(苷基)-β-D-吡喃葡糖(苷基))氧基]对映-贝壳杉-16-烯-19-酸6-O-α-D-吡喃葡糖-β-D-吡喃葡糖(苷基)酯(13-[(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]ent-kaur-16-en-19-oic acid 6-O-α-D-glucopyranose-β-D-glucopyranosyl ester)。
<转葡糖基化蛇菊苷的图>
<转葡糖基化新蛇菊苷A的图>
[表1]
[表2]
虽然已经参考具体的说明性实施方式描述了本公开,但是本公开所属领域的技术人员将理解,在不脱离本公开的技术精神或本质特征的情况下,可以以其他具体形式来体现本公开。因此,上面描述的实施方式在所有方面都被认为是说明性的而不是限制性的。此外,本公开的范围由所附权利要求而不是详细描述来限定,并且应当理解,从本公开的含义和范围及其等同物得出的所有修改或变化都被包括在所附权利要求的范围内。
Claims (6)
1.制备转葡糖基化甜菊醇配糖物的方法,
其中所述方法包括在苹果乳杆菌(Lactobacillus mali)微生物或其培养物的存在下使甜菊醇配糖物与糖反应,
其中所述苹果乳杆菌微生物具有由甜菊醇配糖物转化成转葡糖基化甜菊醇配糖物的特征,
其中所述苹果乳杆菌微生物选自DSM20444、ATCC 27054和ATCC 27304。
2.根据权利要求1所述的方法,其中所述甜菊醇配糖物是选自蛇菊苷、甜茶苷、卫矛醇苷A、新蛇菊苷A、新蛇菊苷C、新蛇菊苷D、新蛇菊苷E、新蛇菊苷F和新蛇菊苷M中的一种或多种。
3.根据权利要求1所述的方法,其中使所述甜菊醇配糖物与所述糖反应是在10℃至60℃的温度下在pH 3至pH 8下进行的。
4.根据权利要求1所述的方法,其中所述转葡糖基化甜菊醇配糖物是甜菊醇配糖物,其中通过凭借与连接到所述甜菊醇配糖物的19-OH位点的葡萄糖经由α-(1,6)键连接来添加葡萄糖。
5.根据权利要求4所述的方法,其中所述转葡糖基化甜菊醇配糖物包含1至4个葡萄糖分子。
6.组合物用于产生所述转葡糖基化甜菊醇配糖物的用途,所述组合物包含苹果乳杆菌微生物或其培养物,
其中所述苹果乳杆菌微生物具有由甜菊醇配糖物转化成转葡糖基化甜菊醇配糖物的特征,
其中所述苹果乳杆菌微生物选自DSM20444、ATCC 27054和ATCC 27304。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2017-0173569 | 2017-12-15 | ||
KR20170173569 | 2017-12-15 | ||
PCT/KR2018/015926 WO2019117667A1 (ko) | 2017-12-15 | 2018-12-14 | 락토바실러스 말리를 이용하여 포도당전이 스테비올 배당체를 제조하는 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111448322A CN111448322A (zh) | 2020-07-24 |
CN111448322B true CN111448322B (zh) | 2024-05-14 |
Family
ID=65479772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880079763.6A Active CN111448322B (zh) | 2017-12-15 | 2018-12-14 | 使用苹果乳杆菌制造转果糖基化甜菊醇配糖物的方法 |
Country Status (13)
Country | Link |
---|---|
US (1) | US12053005B2 (zh) |
EP (1) | EP3708672B1 (zh) |
JP (1) | JP6967153B2 (zh) |
KR (3) | KR20190072471A (zh) |
CN (1) | CN111448322B (zh) |
AR (1) | AR115191A1 (zh) |
DK (1) | DK3708672T3 (zh) |
ES (1) | ES2926074T3 (zh) |
HU (1) | HUE059307T2 (zh) |
PL (1) | PL3708672T3 (zh) |
TW (1) | TWI699165B (zh) |
UY (1) | UY38008A (zh) |
WO (1) | WO2019117667A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102303415B1 (ko) * | 2019-06-14 | 2021-09-23 | 씨제이제일제당 (주) | 감미 소재 조성물 및 이의 제조 방법 |
KR102303661B1 (ko) * | 2019-06-14 | 2021-09-23 | 씨제이제일제당 주식회사 | 포도당 전이 효소를 포함하는 포도당 전이 스테비올 배당체 생산용 조성물 및 이를 이용한 포도당 전이 스테비올 배당체 제조방법 |
KR102546737B1 (ko) | 2020-11-25 | 2023-06-22 | 씨제이제일제당 주식회사 | 포도당 전이 스테비아를 포함하는 감미질이 개선된 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011125256A (ja) * | 2009-12-17 | 2011-06-30 | Mercian Corp | S−3−(ヘキサン−1−オール)−l−システインの製造方法 |
WO2013019050A2 (ko) * | 2011-07-29 | 2013-02-07 | 한국생명공학연구원 | 신규한 α-글루코실 스테비오사이드 및 이의 제조 방법 |
WO2016144175A1 (en) * | 2015-03-10 | 2016-09-15 | Rijksuniversiteit Groningen | Methods for the enzymatic modification of steviol glycosides, modified steviol glycosides obtainable thereby, and the use thereof as sweeteners |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4219571A (en) * | 1978-06-15 | 1980-08-26 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Process for producing a sweetener |
JPH0434813A (ja) | 1990-05-30 | 1992-02-05 | Hitachi Ltd | 高速度遮断器 |
KR950002868B1 (ko) | 1991-11-21 | 1995-03-27 | 주식회사 미원 | 프락토실 스테비오사이드의 제조방법 및 그를 주성분으로 하는 감미료 |
MX2013010690A (es) * | 2011-03-22 | 2014-04-30 | Purecircle Usa | Composicion de glicosido de esteviol glucosilado como un aumentador de gusto y sabor. |
KR101199821B1 (ko) * | 2011-06-23 | 2012-11-09 | 전남대학교산학협력단 | 당 전이 효소를 이용한 기능성 천연 고감미 올리고 배당체 제조 |
KR101724569B1 (ko) * | 2011-07-29 | 2017-04-07 | 한국생명공학연구원 | 루부소사이드 생산하는 신규 제조방법 |
CN102492757B (zh) * | 2011-11-25 | 2014-04-09 | 中国农业大学 | 一种用β-环糊精葡萄糖基转移酶提高甜菊糖苷味质的方法 |
KR101767606B1 (ko) | 2013-10-21 | 2017-08-11 | 한국생명공학연구원 | 유산균을 이용하여 스테비오사이드로부터 루부소사이드를 생산하는 방법 |
TWI559925B (en) * | 2015-08-05 | 2016-12-01 | Univ Nat Taiwan | Novel lactobacillus mali aps1 and use thereof |
-
2018
- 2018-12-14 UY UY0001038008A patent/UY38008A/es unknown
- 2018-12-14 CN CN201880079763.6A patent/CN111448322B/zh active Active
- 2018-12-14 AR ARP180103654A patent/AR115191A1/es unknown
- 2018-12-14 PL PL18889759.9T patent/PL3708672T3/pl unknown
- 2018-12-14 EP EP18889759.9A patent/EP3708672B1/en active Active
- 2018-12-14 JP JP2020529723A patent/JP6967153B2/ja active Active
- 2018-12-14 WO PCT/KR2018/015926 patent/WO2019117667A1/ko unknown
- 2018-12-14 KR KR1020180162185A patent/KR20190072471A/ko not_active IP Right Cessation
- 2018-12-14 DK DK18889759.9T patent/DK3708672T3/da active
- 2018-12-14 TW TW107145268A patent/TWI699165B/zh active
- 2018-12-14 US US16/768,421 patent/US12053005B2/en active Active
- 2018-12-14 HU HUE18889759A patent/HUE059307T2/hu unknown
- 2018-12-14 ES ES18889759T patent/ES2926074T3/es active Active
-
2020
- 2020-07-10 KR KR1020200085619A patent/KR20200087735A/ko not_active IP Right Cessation
-
2021
- 2021-09-03 KR KR1020210117571A patent/KR102421798B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011125256A (ja) * | 2009-12-17 | 2011-06-30 | Mercian Corp | S−3−(ヘキサン−1−オール)−l−システインの製造方法 |
WO2013019050A2 (ko) * | 2011-07-29 | 2013-02-07 | 한국생명공학연구원 | 신규한 α-글루코실 스테비오사이드 및 이의 제조 방법 |
WO2016144175A1 (en) * | 2015-03-10 | 2016-09-15 | Rijksuniversiteit Groningen | Methods for the enzymatic modification of steviol glycosides, modified steviol glycosides obtainable thereby, and the use thereof as sweeteners |
Non-Patent Citations (3)
Title |
---|
Akira Seto et al..Effective cellulose production by a coculture of Gluconacetobacter xylinus and Lactobacillus mali.《Appl Microbiol Biotechnol》.2006,第73卷摘要,第916页左栏. * |
Gerrit J. Gerwig et al..Structural analysis of rebaudioside A derivatives obtained by Lactobacillus reuteri 180 glucansucrase-catalyzed trans-α-glucosylation.《Carbohydrate Research》.2017,第440卷(第22期),51-62. * |
Indra Prakash et al..Development of Next Generation Stevia Sweetener: Rebaudioside M .《Foods》.2014,第3卷162-175. * |
Also Published As
Publication number | Publication date |
---|---|
KR20200087735A (ko) | 2020-07-21 |
EP3708672A1 (en) | 2020-09-16 |
KR20210114899A (ko) | 2021-09-24 |
JP2021503942A (ja) | 2021-02-15 |
TWI699165B (zh) | 2020-07-21 |
CN111448322A (zh) | 2020-07-24 |
UY38008A (es) | 2019-01-31 |
KR20190072471A (ko) | 2019-06-25 |
JP6967153B2 (ja) | 2021-11-17 |
AR115191A1 (es) | 2020-12-09 |
TW201940079A (zh) | 2019-10-16 |
KR102421798B1 (ko) | 2022-07-19 |
ES2926074T3 (es) | 2022-10-21 |
EP3708672B1 (en) | 2022-08-10 |
PL3708672T3 (pl) | 2022-09-26 |
DK3708672T3 (da) | 2022-09-12 |
US20200383364A1 (en) | 2020-12-10 |
HUE059307T2 (hu) | 2022-11-28 |
EP3708672A4 (en) | 2020-12-16 |
US12053005B2 (en) | 2024-08-06 |
WO2019117667A1 (ko) | 2019-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102421798B1 (ko) | 락토바실러스 말리를 이용하여 포도당전이 스테비올 배당체를 제조하는 방법 | |
KR20130014227A (ko) | 신규한 α-글루코실 스테비오사이드 및 이의 제조 방법 | |
CN111511909B (zh) | 应用节杆菌属微生物制备转果糖基甜菊苷的方法 | |
JP2904687B2 (ja) | 新規オリゴ糖 | |
JP7410972B2 (ja) | フルクトース転移ステビオール配糖体を含む組成物 | |
JP3871222B2 (ja) | 新規オリゴ糖、新規オリゴ糖を添加した食品、その製造方法、非う蝕性食品組成物、及びビフィズス菌増殖組成物 | |
CN113507842A (zh) | 包含转糖基化甜菊苷和转糖基化瑞鲍迪甙a的组合物 | |
JPH0633309B2 (ja) | 新規なステビオール配糖体、その製造方法及びこれを用いた甘味料 | |
JP7481350B2 (ja) | 甘味素材組成物およびその製造方法 | |
WO2024010442A1 (en) | High-purity steviol glycosides | |
EP4363431A1 (en) | High-purity steviol glycosides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |